Smith & Nephew PLC
SN.L- Latest Trade
- trading higher1,294GBp
- Change
- 18
- % Change
1.41%Positive
- Day Range
- 1,265.50 - 1,294.00
- 52-Week Range
- 1,151.50 - 1,601.50
As of May 16 2022. Values delayed up to 15 minutes
- Previous Close
- 1,276.00
- Open
- 1,270.50
- Volume
- 1,598,241.00
- 3 Month Average Trading Volume
- 55.18
- Shares Out (Mil)
- 872.37
- Market Capitalization
- 11,075.13
- Forward P/E
- 18.55
- Dividend Yield
- 2.26
Key Statistics
2.42857143 mean rating - 14 analysts
- P/E Excl. Extra Items (TTM)
- 26.10
- Price To Sales (TTM)
- 2.61
- Price To Book (Quarterly)
- 2.46
- Price To Cash Flow (Per Share TTM)
- 12.45
- Total Debt/Total Equity (Quarterly)
- 59.97
- Long Term Debt/Equity (Quarterly)
- 51.15
- Return On Investment (TTM)
- 5.79
- Return On Equity (TTM)
- 4.78
2021 (millions USD)
About Smith & Nephew PLC
Company Information
Smith & Nephew plc is a medical technology company. The Company is engaged in designing and manufacturing technology. It supports healthcare professionals to return their patients to health and mobility by helping them to perform. It serves its customers through global franchises, which includes Orthopaedics, Sports Medicine and Ear, Nose and Throat (ENT) and Advanced Wound Management. The Orthopaedics includes a range of Hip and Knee Implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that allow surgeons, and Trauma products used to stabilize severe fractures and correct bone deformities. Its Sports Medicine and ENT businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a set of products to meet clinical needs, to help healthcare professionals reduce the human and economic consequences of wounds.
Address
Building 5, Croxley Park, Hatters LaneWATFORD, null
WD18 8YE
United Kingdom
Industry
Medical Equipment & Supplies
Executive Leadership
- Roberto Quarta
- Non-Executive Independent Chairman of the Board
- Deepak S. Nath
- Chief Executive Officer
- Anne-Francoise Michele Nesmes
- Chief Financial Officer, Executive Director
- Brad Cannon
- President - Sports Medicine & ENT
- Peter Coenen
- President - EMEA Region
- Myra Eskes
- President - Asia Pacific
- Simon Fraser
- President - Advanced Wound Management and Global Commercial Operations
- Vasant Padmanabhan
- President - Research & Development
- Elga Lohler
- Chief Human Resource Officer
- Phil Cowdy
- Chief Business Development and Corporate Affairs Officer
- Susan Swabey
- Company Secretary
- Jo Hallas
- Non-Executive Director
- Erik Engstrom
- Non-Executive Independent Director
- Robin Anthony David Freestone
- Senior Non-Executive Independent Director
- John Ma
- Non-Executive Independent Director
- Katarzyna Mazurhofsaess
- Non-Executive Independent Director
- Rick Medlock
- Non-Executive Independent Director
- Marc E. Owen
- Non-Executive Independent Director
- Angie Risley
- Non-Executive Independent Director
- Bob White
- Non-Executive Independent Director
Latest News
- FundsEUROPE RESEARCH ROUNDUP Hunting, Molten Ventures, Temenos
Securities analysts revised their ratings and price targets on several European companies, including Hunting, Molten Ventures and Temenos AG on Thursday.
- Healthcare & PharmaceuticalsSmith+Nephew names new CEO as it navigates supply snags, pandemic
British medical products maker Smith+Nephew on Tuesday named a new chief executive to succeed Roland Diggelmann after meeting annual profit and sales forecasts.
- Asian MarketsUK Stocks Factors to watch on Feb 22
Britain's FTSE 100 index is seen opening lower on Tuesday, with futures down 1.27%.
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,813.50 | -- |
| Copper | 759.55 | 0.88%Positive |
| Brent Crude Oil | 114.24 | -- |
| CBOT Soybeans | 1,656.50 | -- |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,008.01 | 0.39%Negative |
| Euro STOXX 50 | 3,685.34 | 0.49%Negative |
| FTSE 100 | 7,464.80 | 0.63%Positive |
| Nikkei 225 | 26,547.05 | -- |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes